Analysis of PET parameters predicting response to radiotherapy for myeloid sarcoma.
Kyu-Hye ChoiJin Ho SongYoo-Kang KwakJong Hoon LeeHong Seok JangPublished in: PloS one (2021)
Good metabolic responses (complete or partial) to radiotherapy were achieved in 92.6% of the myeloid sarcoma patients. Radiation doses < 3000 cGy10 and increased SUVmax were related to treatment failure and high SUVmax before radiotherapy was a factor influencing SUVmax reduction. Further large-scale studies are needed.
Keyphrases
- early stage
- radiation induced
- locally advanced
- end stage renal disease
- radiation therapy
- dendritic cells
- bone marrow
- ejection fraction
- newly diagnosed
- chronic kidney disease
- acute myeloid leukemia
- computed tomography
- prognostic factors
- squamous cell carcinoma
- rectal cancer
- immune response
- patient reported outcomes
- pet imaging